Atlantic American Corp
AAME Nasdaq Life Insurance Financials FY2016βFY2025
What Atlantic American Corp does
No business description yet.
- Legal name
- ATLANTIC AMERICAN CORP
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Oct 16, 2026
- Accession Β· CIK
- 0001140361-26-039933
0000008177
Revenue and margins
Atlantic American Corp had $210M of revenue in fiscal 2025, up 11.9% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 10.9% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $32.4M in fiscal 2025, 15.4% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Atlantic American Corp returned $0.4M to shareholders in fiscal 2025, 1% of free cash flow. The diluted share count fell 0.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Atlantic American Corp can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $24.8M | $28.9M | $28.3M | $35.6M | $43.6M |
| Interest coverage | β1.1x | 4.9x | 0.5x | β0.4x | 1.2x |
| Total assets | $402M | $367M | $379M | $382M | $434M |
| Total liabilities | $261M | $265M | $274M | $271M | $313M |
| Shareholders' equity | $141M | $102M | $106M | $111M | $121M |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 |
| Accruals ratio | 0.4% | β2.3% | β1.5% | 0.4% | 0.8% | 0.8% | β1.3% | β0.7% | β1.6% | β6.6% |
| Altman Z'' | β | β | β | β | β | β | β | β | β | β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $166M | $181M | $186M | $198M | $195M | $200M | $188M | $187M | $188M | $210M |
| Provision for credit losses | β | β | β | β | β | β | $0.0M | $0.0M | β$0.0M | β$0.0M |
| Operating income | $0.9M | β$3.8M | β$3.9M | β$7.5M | $11.5M | β$1.5M | $9.6M | $1.5M | β$1.3M | $3.7M |
| Interest expense | $1.6M | $1.7M | $2.0M | $2.1M | $1.6M | $1.4M | $2.0M | $3.3M | $3.4M | $3.1M |
| Pretax income | $3.5M | $5.4M | β$1.0M | β$0.4M | $15.5M | $5.3M | $2.1M | β$0.6M | β$1.6M | $7.7M |
| Income tax | $0.9M | $0.8M | β$0.3M | β$0.0M | $3.3M | $1.0M | $0.6M | β$0.4M | β$0.2M | $1.7M |
| Net income | $2.6M | $4.5M | β$0.7M | β$0.4M | $12.2M | $4.3M | $1.5M | β$0.2M | β$1.4M | $6.0M |
| Net income to common | $2.2M | $4.1M | β$1.1M | β$0.8M | $11.8M | $3.9M | $1.1M | β$0.6M | β$1.8M | $5.6M |
| Diluted EPS | $0.11 | $0.20 | β$0.05 | β$0.04 | $0.56 | $0.19 | $0.06 | β$0.03 | β$0.09 | $0.28 |
| Diluted shares | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B |
| Cash flow | ||||||||||
| Cash from operations | $1.3M | $12.2M | $4.5M | β$1.8M | $9.0M | $1.1M | $6.5M | $2.6M | $4.8M | $32.9M |
| Capital expenditure | $0.4M | $0.1M | $0.3M | $0.1M | $0.2M | $0.1M | $0.1M | $0.1M | $0.2M | $0.5M |
| Free cash flow | $0.9M | $12.1M | $4.2M | β$1.9M | $8.7M | $1.0M | $6.3M | $2.5M | $4.6M | $32.4M |
| Depreciation and amortization | $1.2M | $1.4M | $1.0M | $1.0M | $1.0M | $1.0M | $0.9M | $0.7M | $0.4M | $0.4M |
| Stock-based compensation | $0.6M | $0.5M | $0.2M | $0.4M | $0.4M | $0.2M | $0.1M | $0.1M | $0.0M | $0.0M |
| Share buybacks | $0.7M | $0.7M | $0.6M | $0.1M | $0.0M | β | β | β | β | β |
| Dividends paid | $0.4M | $0.4M | $0.4M | $0.4M | $0.0M | $0.4M | $0.4M | $0.4M | $0.4M | $0.4M |
| Dividends and buybacks | $1.1M | $1.1M | $1.0M | $0.5M | $0.0M | $0.4M | $0.4M | $0.4M | $0.4M | $0.4M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $13.3M | $24.5M | $12.6M | $12.9M | $19.3M | $24.8M | $28.9M | $28.3M | $35.6M | $43.6M |
| Total assets | $319M | $343M | $344M | $378M | $405M | $402M | $367M | $379M | $382M | $434M |
| Total liabilities | $213M | $230M | $243M | $259M | $260M | $261M | $265M | $274M | $271M | $313M |
| Preferred stock | $0.1M | $0.1M | $0.1M | $0.1M | $0.1M | $0.1M | $0.1M | $0.1M | $0.1M | $0.1M |
| Shareholders' equity | $106M | $113M | $101M | $118M | $145M | $141M | $102M | $106M | $111M | $121M |
| Margins | ||||||||||
| Operating margin | 0.6% | β2.1% | β2.1% | β3.8% | 5.9% | β0.7% | 5.1% | 0.8% | β0.7% | 1.8% |
| EBITDA margin | 1.3% | β1.3% | β1.6% | β3.3% | 6.4% | β0.2% | 5.6% | 1.2% | β0.5% | 2.0% |
| Net margin | 1.6% | 2.5% | β0.4% | β0.2% | 6.2% | 2.1% | 0.8% | β0.1% | β0.7% | 2.9% |
| FCF margin | 0.6% | 6.7% | 2.3% | β0.9% | 4.5% | 0.5% | 3.4% | 1.4% | 2.4% | 15.4% |
| Returns | ||||||||||
| Return on equity | 2.5% | 4.1% | β0.7% | β0.4% | 9.2% | 3.0% | 1.3% | β0.2% | β1.3% | 5.2% |
| Return on assets | 0.8% | 1.4% | β0.2% | β0.1% | 3.1% | 1.1% | 0.4% | β0.0% | β0.4% | 1.5% |
| Return on tangible equity | 2.1% | 3.7% | β1.1% | β0.7% | 8.1% | 2.7% | 1.1% | β0.5% | β1.6% | 4.7% |
| Growth | ||||||||||
| Revenue growth | β | 9.1% | 2.5% | 6.8% | β1.4% | 2.2% | β5.9% | β0.6% | 0.7% | 11.9% |
| Net income growth | β | 71.8% | β115.5% | β | β | β64.8% | β64.4% | β111.2% | β | β |
| EPS growth | β | 81.8% | β125.0% | β | β | β66.1% | β68.4% | β150.0% | β | β |
| FCF growth | β | 1,211.5% | β65.4% | β144.9% | β | β88.8% | 545.0% | β59.8% | 80.0% | 608.4% |
| Share count change | β | β0.1% | β0.7% | β0.1% | 7.7% | β6.5% | β0.1% | 0.1% | β0.0% | β0.0% |
| Financial health | ||||||||||
| Interest coverage | 0.6x | β2.2x | β1.9x | β3.5x | 7.2x | β1.1x | 4.9x | 0.5x | β0.4x | 1.2x |
| Capital allocation | ||||||||||
| Capex / revenue | 0.2% | 0.1% | 0.2% | 0.0% | 0.1% | 0.1% | 0.1% | 0.0% | 0.1% | 0.2% |
| Stock comp / revenue | 0.4% | 0.3% | 0.1% | 0.2% | 0.2% | 0.1% | 0.1% | 0.1% | 0.0% | 0.0% |
| Payouts / FCF | 120.2% | 9.1% | 24.0% | β | 0.0% | 41.6% | 6.4% | 16.1% | 8.9% | 1.3% |
| Quality scores | ||||||||||
| Accruals ratio | 0.4% | β2.3% | β1.5% | 0.4% | 0.8% | 0.8% | β1.3% | β0.7% | β1.6% | β6.6% |
Source: SEC EDGAR XBRL filings (CIK 0000008177). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.